scispace - formally typeset
Y

Yuhlong Lio

Researcher at University of South Dakota

Publications -  95
Citations -  1281

Yuhlong Lio is an academic researcher from University of South Dakota. The author has contributed to research in topics: Estimator & Censoring (clinical trials). The author has an hindex of 17, co-authored 80 publications receiving 1074 citations. Previous affiliations of Yuhlong Lio include National Chiao Tung University & University of South Carolina.

Papers
More filters
Journal ArticleDOI

Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer

TL;DR: The findings show the aberrant expression of MUC13 in ovarian cancer and that its expression alters the cellular characteristics of SKOV-3 cells, which implies a significant role of M UC13 in Ovarian cancer.
Journal ArticleDOI

Acceptance Sampling Plans from Truncated Life Tests Based on the Birnbaum–Saunders Distribution for Percentiles

TL;DR: In this article, acceptance sampling plans are developed for the Birnbaum–Saunders distribution percentiles when the life test is truncated at a pre-specified time to ensure the specified life percentile is obtained under a given customer's risk.
Journal ArticleDOI

Acceptance sampling plans from truncated life tests based on the Burr type XII percentiles

TL;DR: In this paper, acceptance sampling plans are developed for the Burr type XII distribution percentiles when the life test is truncated at a pre-specified time, and the minimum sample size necessary to ensure the specified life percentile is obtained under a given customer's risk.
Journal ArticleDOI

MUC13 Mucin Augments Pancreatic Tumorigenesis

TL;DR: A role of MUC13 in pancreatic cancer is investigated and its potential use as a diagnostic and therapeutic target is suggested.
Journal ArticleDOI

Parameter estimations for generalized exponential distribution under progressive type-I interval censoring

TL;DR: The estimates, via maximum likelihood, moment method and probability plot, of the parameters in the generalized exponential distribution under progressive type-I interval censoring are studied and applied to a real data set based on patients with plasma cell myeloma in order to demonstrate the applicabilities.